Live Biotherapeutic Products And Microbiome Contract Manufacturing Market Size, Share & Trends Analysis Report By Product Manufactured (APIs, FDFs), By Type of Formulations, By Scale of operations, By Company Size, By Application, By Region, And By Segment Forecasts, 2023-2031.

Report ID : 1152 | Published : 2023-05-02 | Pages: 190 | Format:

The Live Biotherapeutic Products And Microbiome Contract Manufacturing Market Size is valued at 79.89 Million in 2022 and is predicted to reach 1077.17 Million by the year 2031 at a 28.9 % CAGR during the forecast period for 2023-2031.

Live Biotherapeutic Products And Microbiome Contract Manufacturing Market

The Human Microbiome is the group of loads of microbes living on and in the human body. The microbiomes are found, for example, in the skin, gut, mouth, and vagina.  A live biotherapeutic product comprises a live microorganism used for the cure or treatment and prevention of disease. The live biotherapeutic industry is experiencing enormous research and development activities to develop products for various diseases and applications.

Till now, about 200 companies are developing microbiome-based therapies anticipated to treat an extensive range of severe diseases, with big pharmaceutical companies showing augmented interest by associating with early innovators. Most of the clinical treatment is under the preclinical stage, various are under clinical development, and about 15 are in phase II/III trials of development. The commercialization of these products in the coming years is expected to generate a huge potential for the growth of the market over the estimated timeframe. However, the lack of a satisfactory manufacturing capacity of the innovators may significantly hinder the market's growth. Additionally, lack of the essential industry standards associated with live biotherapeutics manufacturing, batch-to-batch reliability-related concerns, lack of infrastructure, and uncertainties related to product approval and regulatory review are some of the factors affecting market growth substantially. However, a growing number of deals among various developers for contract manufacturing is projected to generate immense opportunities for the market's growth globally.

Market Segmentation

The Global Live Biotherapeutic Products and Microbiome Contract Manufacturing Market is segmented on the basis of product manufactured, type of formulation, the scale of operation, company size, and region. The market is divided into Active Pharmaceutical Ingredients (APIs) and Finished Drug Formulations (FDFs) based on the product manufactured. Based on the type of formulation, the market is segmented into solid formulations, oral liquids, injectables, and others. Based on the scale of operation, the market is categorized into, preclinical scale operations, clinical scale operations, and commercial-scale operations. By company size, live biotherapeutic products and microbiome contract manufacturing market is segmented into small-sized companies, mid-sized companies, and large companies. Also, in case of applications segment it is catagorised as C.difficle, Crohns disease, IBS, Diabetes and Others. Based on the region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA.

Competitive Landscape

Some major key players in the Live Biotherapeutic Products And Microbiome Contract Manufacturing Market:

  • Quay Pharmaceuticals,
  • Cobra Biologics Limited,
  • Cerbios-Pharma SA,
  • List Biological Labs, Inc.,
  • Arranta Bio,
  • BacThera,
  • Luina Bio Pty Ltd,
  • 4D pharma plc,
  • Paras Biopharmaceuticals Finland Oy,
  • Capsugel, Deerland Probiotics & Enzymes,
  • Paragon Bioservices,
  • UAS Labs,
  • Biose,
  • Cobra Biologics,
  • Cerbios,
  • Inpac Probiotics,
  • BJP Laboratories,
  • S-Biomedic,
  • Meteoric Biopharmaceuticals,
  • BiomX,
  • Universal Stabilization Technologies,
  • Assembly Biosciences,
  • Wacker Biotech,
  • Chung Mei Pharmaceutical
  • Lonza

Live Biotherapeutic Products And Microbiome Contract Manufacturing Market Report Scope

Report Attribute

Specifications

Market Size Value In 2022

USD 79.89 Million

Revenue Forecast In 2031

USD 1077.17 Million

Growth Rate CAGR

CAGR of 28.9 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Product Manufactured, Type of Formulations, Scale of operations, Company size, Application

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Quay Pharmaceuticals, Cobra Biologics Limited, Cerbios-Pharma SA, List Biological Labs, Inc., Arranta Bio, BacThera, Luina Bio Pty Ltd, 4D pharma plc, Paras Biopharmaceuticals Finland Oy, Capsugel, Deerland Probiotics & Enzymes, Paragon Bioservices, UAS Labs, Biose, Cobra Biologics, Cerbios, Inpac Probiotics, BJP Laboratories, S-Biomedic, Meteoric Biopharmaceuticals, BiomX, Universal Stabilization Technologies, Assembly Biosciences, Wacker Biotech,  and Chung Mei Pharmaceutical, Lonza.

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1.           Methodology and Scope

1.1.         Research Methodology

1.2.         Research Scope & Assumptions

Chapter 2.           Executive Summary

Chapter 3.           Global Live Biotherapeutic Products And Microbiome Contract Manufacturing Market Snapshot

Chapter 4.           Global Live Biotherapeutic Products And Microbiome Contract Manufacturing Market Variables, Trends & Scope

4.1.         Market Segmentation & Scope

4.2.         Drivers

4.3.         Challenges

4.4.         Trends

4.5.         Investment and Funding Analysis

4.6.         Industry Analysis – Porter’s Five Forces Analysis

4.7.         Competitive Landscape & Market Share Analysis

4.8.         Impact of Covid-19 Analysis

Chapter 5.           Market Segmentation 1: By Product Manufactured, Estimates & Trend Analysis

5.1.         By Product Manufactured, & Market Share, 2019 & 2031

5.2.         Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Product Manufactured:

5.2.1.     APIs

5.2.2.     FDFs

Chapter 6.           Market Segmentation 2: By Type of Formulations Estimates & Trend Analysis

6.1.         By Type of Formulations & Market Share, 2019 & 2031

6.2.         Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Type of Formulations:

6.2.1.     Solid Formulations

6.2.2.     Oral Liquids

6.2.3.     Injectables

6.2.4.     Others

Chapter 7.           Market Segmentation 3: By Scale of operations Estimates & Trend Analysis

7.1.         By Scale of operations & Market Share, 2019 & 2031

7.2.         Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Scale of operations:

7.2.1.     Preclinical Scale Operations

7.2.2.     Clinical Scale Operations

7.2.3.     Commercial Scale Operations

Chapter 8.           Market Segmentation 4: By Company size Estimates & Trend Analysis

8.1.         By Company size & Market Share, 2019 & 2031

8.2.         Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Company size:

8.2.1.     Small-sized Companies

8.2.2.     Mid-sized Companies

8.2.3.     Large Companies

Chapter 9.           Market Segmentation 5: By Application Estimates & Trend Analysis

9.1.         By Application & Market Share, 2019 & 2031

9.2.         Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Application:

9.2.1.     Breast Cancer

9.2.2.     Colorectal Cancer

9.2.3.     Cervical Cancer

9.2.4.     Gastrointestinal Cancer

9.2.5.     Lung Cancer

9.2.6.     Prostate Cancer

9.2.7.     Other Indications

Chapter 10.         Live Biotherapeutic Products And Microbiome Contract Manufacturing Market Segmentation 6: Regional Estimates & Trend Analysis

10.1.      North America

10.1.1.   North America Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Product Manufactured, 2023-2031

10.1.2.   North America Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Type of Formulations, 2023-2031

10.1.3.   North America Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Scale of operations, 2023-2031

10.1.4.   North America Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Company size, 2023-2031

10.1.5.   North America Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Application, 2023-2031

10.1.6.   North America Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by country, 2023-2031

10.2.      Europe

10.2.1.   Europe Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) By Product Manufactured, 2023-2031

10.2.2.   Europe Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) By Type of Formulations, 2023-2031

10.2.3.   Europe Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) By Scale of operations, 2023-2031

10.2.4.   Europe Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Company size, 2023-2031

10.2.5.   Europe Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Application, 2023-2031

10.2.6.   Europe Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) by country, 2023-2031

10.3.      Asia Pacific

10.3.1.   Asia Pacific Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) By Product Manufactured, 2023-2031

10.3.2.   Asia Pacific Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) By Type of Formulations, 2023-2031

10.3.3.   Asia Pacific Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) By Scale of operations, 2023-2031

10.3.4.   Asia Pacific Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Company size, 2023-2031

10.3.5.   Asia Pacific Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Application, 2023-2031

10.3.6.   Asia Pacific Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) by country, 2023-2031

10.4.      Latin America

10.4.1.   Latin America Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) By Product Manufactured, (US$ Million) 2023-2031

10.4.2.   Latin America Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) By Type of Formulations, (US$ Million) 2023-2031

10.4.3.   Latin America Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) By Scale of operations, (US$ Million) 2023-2031

10.4.4.   Latin America Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Company size, 2023-2031

10.4.5.   Latin America Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Application, 2023-2031

 

10.4.6.   Latin America Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) by country, 2023-2031

10.5.      Middle East & Africa

10.5.1.   Middle East & Africa Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) By Product Manufactured, (US$ Million) 2023-2031

10.5.2.   Middle East & Africa Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) By Type of Formulations, (US$ Million) 2023-2031

10.5.3.   Middle East & Africa Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) By Scale of operations, (US$ Million) 2023-2031

10.5.4.   Middle East & Africa Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Company size, 2023-2031

10.5.5.   Middle East & Africa Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Application, 2023-2031

10.5.6.   Middle East & Africa Live Biotherapeutic Products And Microbiome Contract Manufacturing Market revenue (US$ Million) by country, 2023-2031

Chapter 11.         Competitive Landscape

11.1.      Major Mergers and Acquisitions/Strategic Alliances

11.2.      Company Profiles

11.2.1.   PathAI

11.2.2.   Paige.AI

11.2.3.   Akoya Biosciences

11.2.4.   Aiforia

11.2.5.   aetherAI

11.2.6.   CellCarta

11.2.7.   Deep Bio Inc.

11.2.8.   DoMore Diagnostics

11.2.9.   PROSCIA

11.2.10.                Pramana, Inc.

11.2.11.                Visiopharm A/S

11.2.12.                Roche Tissue Diagnostics

11.2.13.                Indica Labs

11.2.14.                Ibex Medical Analytics

11.2.15.                LDPath

11.2.16.                OracleBio Limited

11.2.17.                Verily

11.2.18.                Mindpeak GmbH

11.2.19.                Proscia Inc.

11.2.20.                SamanTree Medical SA

11.2.21.                Tempus AI

11.2.22.                Techcyte, Inc.

11.2.23.                Tribun Health

11.2.24.                Lonza

11.2.25.                Other Prominent Players

Global Live Biotherapeutic Products and Microbiome Contract Manufacturing Market Segmentation:

Global Live Biotherapeutic Products and Microbiome Contract Manufacturing Market by Product Manufactured

  • APIs
  • FDFs

Live Biotherapeutic Products And Microbiome Contract Manufacturing Market

Global Live Biotherapeutic Products and Microbiome Contract Manufacturing Market Based on Type of Formulation

  • Solid Formulations
  • Oral Liquids
  • Injectables
  • Others

Global Live Biotherapeutic Products and Microbiome Contract Manufacturing Market Based on Scale of Operation

  • Preclinical Scale Operations
  • Clinical Scale Operations
  • Commercial Scale Operations

Global Live Biotherapeutic Products and Microbiome Contract Manufacturing Market Based on Company Size

  • Small-sized Companies
  • Mid-sized Companies
  • Large Companies

Global Live Biotherapeutic Products and Microbiome Contract Manufacturing Market Based on Application

  • difficle
  • Crohns disease
  • IBS
  • Diabetes
  • Others

 

Global Live Biotherapeutic Products and Microbiome Contract Manufacturing Market Based on Region

Europe

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America

  • U.S.
  • Canada

Asia Pacific

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Live Biotherapeutic Products And Microbiome Contract Manufacturing Market Size?

The Live Biotherapeutic Products And Microbiome Contract Manufacturing Market is expected to grow at a 28.9 % CAGR during the forecast period for 2023

Quay Pharmaceuticals, Cobra Biologics Limited, Cerbios-Pharma SA, List Biological Labs, Inc., Arranta Bio, BacThera, Luina Bio Pty Ltd, 4D pharma plc,

Our Clients

Media Citations

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$3986
$5986
$8000
$1200
Get a Custom Report
Contact us with a specific research request.

Kindly share us with a topic or product segment or objectives to meet your strategy goals

Review Request

We’ll review your request & send a personalized quote for cost and time needed

Final Delivery

Sit back while our team work on your research. We will send bi-monthly updates and discuss our finding on a conference call upon final delivery..